KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Deferred Taxes (2016 - 2025)

Medpace Holdings' Deferred Taxes history spans 11 years, with the latest figure at $17.4 million for Q4 2025.

  • For Q4 2025, Deferred Taxes rose 171.93% year-over-year to $17.4 million; the TTM value through Dec 2025 reached $80.8 million, up 403.29%, while the annual FY2025 figure was $80.8 million, 403.29% up from the prior year.
  • Deferred Taxes reached $17.4 million in Q4 2025 per MEDP's latest filing, down from $28.5 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $34.1 million in Q2 2025 to a low of -$40.4 million in Q4 2021.
  • Average Deferred Taxes over 5 years is -$1.6 million, with a median of -$719500.0 recorded in 2022.
  • Peak YoY movement for Deferred Taxes: crashed 1006.11% in 2023, then surged 63261.11% in 2025.
  • A 5-year view of Deferred Taxes shows it stood at -$40.4 million in 2021, then surged by 48.31% to -$20.9 million in 2022, then surged by 33.89% to -$13.8 million in 2023, then plummeted by 75.24% to -$24.2 million in 2024, then soared by 171.93% to $17.4 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Deferred Taxes are $17.4 million (Q4 2025), $28.5 million (Q3 2025), and $34.1 million (Q2 2025).